First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers
First-generation GLP-1 weight-loss drugs could help reduce the risk of obesity-related cancers, new research shows. These medications have been around longer than the newer, better-known GLP-1 drugs, such as Ozempic, but they work in similar ways. Experts say a healthy lifestyle that includes a well-balanced diet, regular exercise, and adequate sleep is an important component…